Rafarma Pharmaceuticals, Inc.
RAFA - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.11M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.11 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | 0.7 |
| Outstanding Shares | 87,766,999 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 10.43 |
|---|---|
| PEG | 128.7 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Rafarma Pharmaceuticals, Inc.
700 employees
CEO: Sergey Brusnitsin
Rafarma Pharmaceuticals, Inc. is a diversified pharmaceutical enterprise that manufactures and distributes a range of medicinal products, including generic antibiotics and specialized drugs, within the Russian market. Its product portfol...